In the present study, we disclosed the regulatory roles of EXTL2 and EXTL3 in GAG and HSPG biosynthetic pathways, in the context of gastric cancer, and evaluated the impact of the resulting altered GAGosylation in cancer cells’ motility and signaling features. The gene discussed is EXTL3; the disease is cancer.